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Abstract
West Nile virus (WNV) is a mosquito-borne flavivirus that primarily infects birds but occasionally infects humans and horses.
Certain species of birds, including crows, house sparrows, geese, blue jays and ravens, are considered highly susceptible
hosts to WNV. The nonstructural protein 1 (NS1) of WNV can elicit protective immune responses, including NS1-reactive
antibodies, during infection of animals. The antigenicity of NS1 suggests that NS1-reactive antibodies could provide a basis
for serological diagnostic reagents. To further define serological reagents for diagnostic use, the antigenic sites in NS1 that
are targeted by host immune responses need to be identified and the potential diagnostic value of individual antigenic sites
also needs to be defined. The present study describes comprehensive mapping of common immunodominant linear B-cell
epitopes in the WNV NS1 using avian WNV NS1 antisera. We screened antisera from chickens, ducks and geese immunized
with purified NS1 for reactivity against 35 partially overlapping peptides covering the entire WNV NS1. This study identified
twelve, nine and six peptide epitopes recognized by chicken, duck and goose antibody responses, respectively. Three
epitopes (NS1-3, 14 and 24) were recognized by antibodies elicited by immunization in all three avian species tested. We
also found that NS1-3 and 24 were WNV-specific epitopes, whereas the NS1-14 epitope was conserved among the Japanese
encephalitis virus (JEV) serocomplex viruses based on the reactivity of avian WNV NS1 antisera against polypeptides derived
from the NS1 sequences of viruses of the JEV serocomplex. Further analysis showed that the three common polypeptide
epitopes were not recognized by antibodies in Avian Influenza Virus (AIV), Newcastle Disease Virus (NDV), Duck Plague Virus
(DPV) and Goose Parvovirus (GPV) antisera. The knowledge and reagents generated in this study have potential applications
in differential diagnostic approaches and subunit vaccines development for WNV and other viruses of the JEV serocomplex.
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Introduction
West Nile virus (WNV) is a medically important pathogen that
is prevalent in many areas around world, including Africa,
Europe, Russia, the Middle East, India, Australia and North
America [1]. It is serologically classified into the Japanese
encephalitis virus (JEV) serocomplex, which includes WNV,
JEV, Saint-Louis encephalitis virus (SLEV) and Murray Valley
fever virus (MVEV) [2].
WNV is a mosquito-borne flavivirus that primarily infects birds
but occasionally infects humans and horses. As such, the virus
poses a risk to human health as well as the health of domestic
animals and wildlife. In the first half of 2011, WNV was associated
with 183 clinical neuroinvasive disease cases and 85 clinical non-
neuroinvasive disease cases in humans [3]. The profile of WNV
viremia following mosquito-borne infection of birds can vary
greatly among different bird species [4–6]. Birds that sustained a
viremic titer greater than 10
5.0 plaque forming units (PFU)/ml
were considered infectious to C. pipiens and C. quinquefasciatus [7,8].
Certain species of birds, including crows, geese, blue jays, ravens,
chickens and house sparrows, are considered highly susceptible
hosts for WNV, and may be involved in virus transmission through
mosquito bites because they develop high levels of viremia after
WNV infection [4–6,9–21]. Deaths in American crows (AMCR)
due to WNV infection were especially prevalent in New York
City in 1999 [22], and crow mortality has been adopted as an
epidemiological indicator to monitor WNV transmission in the
United States and has proven useful in predicting an increased risk
for human infection [23–25].
Fortunately, commercially raised chickens and turkeys have
not been extensively affected by WNV, likely because they are
predominantlyraisedindoorsandhavelimitedexposuretomosquito
vectors [26]. Although chickens and turkeys can become infected
with WNV when experimentally inoculated subcutaneously with
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31434WNV, infection results in low viral titers and does not cause clinical
disease [27,28]. Recently, mutations in the prM (prM-I141T) and
envelope 40 (E-S156P) genes were shown to mediate the attenuated
phenotype of the WNV TM171-03-pp1 virus variant in a chicken
macrophage cell line [29]. Once mutated WNV strains were
emergent, the strains with high virulence to chickens even causing
fatality would also arise, so monitoring epidemiology of WNV
infected chickens is necessary. Differences in the course of natural
WNV infection in geese as compared to chickens have also been
noted, as natural WNV infections could cause severe neurological
signs and death in young domestic geese [6,30]. While the role of
domestic geese as a WNV reservoir in an outbreak in Israel is
unknown, the infection rates of geese in the Sindbis District of the
northern Nile Valley were similar to the rates in buffed-back herons
(Bubulcus ibis ibis), doves (Streptopelia senegalensis senegalensis), and
domesticated pigeons (Columbia livia) and twice the rate seen in
domesticated chickens and ducks (Anas platyrhynchos), suggesting that
geese may play a role in local WNV ecology [31].
Flavivirus nonstructural protein 1 (NS1) is an important
nonstructural protein which plays critical roles in viral RNA
replication and the development of flavivirus-associated diseases
[32,33]. Although NS1 protein is not present in the virion of
flaviviruses, it can elicit non-neutralizing protective antibodies that
inhibit infection through both Fc-c receptor-dependent and -
independent mechanisms [34]. Additional works has shown that
passive administration of monoclonal antibody (mAb) against the
NS1 protein or active immunization with the NS1 gene or protein
confer protection from lethal flavivirus challenge [35–39], suggest-
ing that immune responses targeted against the NS1 protein of
flaviviruses play an important rolein conferring immune protection.
A single mAb against flavivirus NS1 protein also could effectively
protect against lethal flavivirus challenge [34,40–44]. While anti-E
mAb-based therapies could be a promising strategy to control
flavivirus infections, sub-neutralizing concentrations of anti-E
antibodies have the potential to cause antibody-dependent
enhancement (ADE) of flavivirus infections that complicate therapy
[45–48]. Targeting the NS1protein usingprotective antibodies may
represent a promising alternative approach.
In future years, it is expected that migratory birds infected
WNV will carry the virus to all parts of the United States as well as
to Canada, the Caribbean, and Central and South America [49].
Mosquitoes capable of transmitting WNV to susceptible birds exist
in each of these regions. The convergence of birds at scarce pools
of water also facilitates virus transmission. Diagnostic platforms to
monitor WNV infection in domestic avian species, including
chickens, ducks and geese, which come into contact with wild
waterfowl and birds would be extremely valuable. The rationale
exploitation of the antigenic peptide epitopes in the WNV NS1
protein that are targeted by avian antibody responses could
provide the basis for such a diagnostic platform.
The aim of our study was to identify immunodominant B-cell
epitopes in the WNV NS1 protein that are targeted by the avian
immune system using chicken, duck and goose antisera raised
against recombinant WNV NS1 protein. The epitopes mapping
described in this report will facilitate the development of diagnostic
tests for the serological detection of WNV infection and the
rationale design of subunit vaccines for WNV and other viruses of
the JEV serocomplex.
Results
Titers of avian antisera
To generate NS1-reactive polyclonal antisera, chickens, ducks
and geese were immunized three times with recombinant WNV
NS1 protein. Antisera were collected two weeks after the third
immunization for epitopes mapping experiments. Immediately
prior to each immunization, serum was collected from each bird to
measure the NS1-reactive antibody titers by immunofluorescence
assay (IFA). As shown in Table 1, the WNV NS1-reactive antibody
titers increased progressively with each sequential immunization in
immunized chickens, ducks and geese. As expected, birds that
were not immunized with NS1 protein did not have detectable
levels of NS1-reactive antibodies at any time point (Table 1).
Finally, the titers of the antisera from chicken, duck and goose
determined by IFA were 1:128, 1:256 and 1:512, respectively.
Therefore, immunization with recombinant WNV NS1 protein
elicits high-titer NS1-reactive antibodies in chickens, ducks and
geese.
Comprehensive mapping of linear WNV NS1 B-cell
epitopes by Western Blot (WB) using avian antisera
We next sought to identify linear epitopes within the WNV NS1
protein that are targeted by the avian antibody responses following
immunization with recombinant WNV NS1 protein. We screened
a series of 35 partially overlapping peptides covering the entire
coding sequence of the WNV NS1 protein using the chicken, duck
and goose antisera against purified WNV NS1 protein by WB.
The NS1-derived peptides were expressed as MBP-fused poly-
peptides for screening. As shown in Table 2, the chicken antisera
recognized twelve NS1 peptides, the duck antisera recognized nine
NS1 peptides, and the goose antisera recognized six NS1 peptides
in the series. Three peptides (NS1-3, 14 and 24) were recognized
by antibodies in the sera of all three avian species following NS1
immunization; seven peptides (NS1-1, 3, 6, 9, 14, 20 and 24) were
recognized by chicken and duck antisera; five peptides (NS1-3, 14,
18, 24 and 27) were recognized by duck and goose antisera; and
four peptides (NS1-3, 14, 24 and 26) were recognized by chicken
and goose antisera (Table 2). As expected, the control avian sera
from unimmunized animals did not detectably react with any of
the 35 MBP-fused polypeptides and MBP-tag only (data not
shown).
Confirmation of the identified WNV NS1 B-cell epitopes
by ELISA using avian antisera
To confirm the reactivity of avian antibodies against the peptide
epitopes identified by the WB, the candidate polypeptides were
synthesized and screened by ELISA using the avian antisera. The
chicken, duck and goose antisera displayed the same pattern of
reactivity against the WNV NS1-derived polypeptides using an
ELISA as was seen in the WB screening against the 35 MBP-fused
polypeptides (Figure 1). Importantly, the antisera of all three avian
species maintained reactivity against the three common NS1
Table 1. Determination of the titers of antisera by IFA.
Titer of antisera Time Points
0 week 2nd week 4th week 5th week 6th week
Chicken antisera ,1:2 1:16 1:64 1:128 1:128
Chicken control ,1:2 ,1:2 ,1:2 ,1:2 ,1:2
Duck antisera ,1:2 1:8 1:64 1:256 1:256
Duck control ,1:2 ,1:2 ,1:2 ,1:2 ,1:2
Goose antisera ,1:2 1:32 1:128 1:256 1:512
Goose control ,1:2 ,1:2 ,1:2 ,1:2 ,1:2
doi:10.1371/journal.pone.0031434.t001
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suggesting these linear epitopes may be of potential value for the
development of serological diagnosis tests. As expected, the control
avian sera from unimmunized animals did not detectably react
with any polypeptide (data not shown).
Evaluation of the conservation of three common
epitopes among JEV serocomplex viruses
We next investigated whether the three linear epitopes in the
WNV NS1 protein were specific to WNV or conserved among
viruses of the JEV serocomplex. To this end, we aligned the NS1
amino acid sequences from viruses of the JEV serocomplex and
antigenically related flaviviruses to identify the sequences corre-
sponding to the three commonly recognized linear epitopes
identified in the WNV NS1 protein (Figure 2, right panels). The
corresponding polypeptides from other viruses of the JEV
serocomplex were also synthesized and screened using the avian
antisera raised against WNV NS1 protein to evaluate antibody
cross-reactivity. The NS1-3 and 24 linear peptide epitopes, located
at amino acids 21–36 and 231–246 of the WNV NS1 protein,
were specific to WNV, as the three avian antisera did not react
with polypeptides derived from the corresponding region of the
JEV serocomplex members JEV, MVEV and SLEV (Figure 2A
and C, left panels). The NS1-14 epitope, located at amino acids
131–146 of WNV, was common to all the JEV serocomplex
viruses tested, as the avian antisera recognized the corresponding
polypeptides derived from JEV, MVEV and SLEV (Figure 2B, left
panel). As expected, the control avian sera from unimmunized
animals did not detectably react with any polypeptide (data not
shown).
Assessment of specificity of the three common peptide
epitopes
Finally, we sought to determine whether antibodies generated
against Avian Influenza Virus (AIV), Newcastle Disease Virus
(NDV), Duck Plague Virus (DPV) and Goose Parvovirus (GPV)
could react with the three common WNV NS1 peptide epitopes
that were targeted by avian species following immunization with
WNV NS1 protein. AIV, NDV, DPV and GPV antisera did not
react with the three WNV NS1 epitopes (NS1-3, 14 and 24), as
indicated by an optical density (OD) lower than 0.2 at 492 nm
(Figure 3). As expected, the control avian sera did not react with
any polypeptide (data not shown). These data indicate that
antibodies generated against other viruses, including AIV, NDV,
DPV and GPV, do not cross react with the NS1-3, 14 and 24
linear WNV NS1 epitopes, and strongly suggest that these epitopes
are specific to WNV and/or JEV serocomplex viruses.
Discussion
The differential diagnosis of WNV and related flaviviruses has
long been a challenge. The practical application of serological
diagnostic tests, including the virus neutralization test, the
hemagglutination-inhibiting test, ELISA and IFA are limited by
biosafety concerns [50]. Antibody cross-reactivity among members
of the JEV serocomplex and other flaviviruses can confound the
diagnostic outcome [51,52], especially in geographic regions
where several flaviviruses coexist [17]. Several studies have used
a WNV NS1-specific mAb to detect natural infections among
vaccinated populations and also to differentiate WNV from JEV
infections in horses [53–56]. These studies illustrate that the NS1
protein can be exploited as a platform for the differential diagnosis
of WNV and JEV serocomplex viruses. In addition to the potential
utility of antibodies as diagnostic reagents, antibodies that bind
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several ways, including virus neutralization and opsonization. The
identification of antibody binding viral epitopes is required to
understand antigenic composition of viral proteins and virus-
antibody interactions at a molecular level.
In this study, we immunized three avian species using
recombinant WNV NS1 protein and used the antisera to
comprehensively map linear B-cell epitopes in the WNV NS1
protein. Following immunization, each avian species developed
antibodies against some WNV NS1-derived polypeptides. We
identified three WNV NS1-derived polypeptides that were
commonly recognized by the antisera of all three avian species
tested. We also identified other WNV NS1 peptide epitopes that
were differentially recognized by chicken, duck and goose antisera
following immunization. Some differences among the antibody
specificities of mammalian and avian species were noted when we
compared the NS1 epitopes recognized by avian antisera with
epitopes previously identified using murine antisera and murine
mAbs (Table 2) [57]. Despite some differences in the epitopes
recognized among different species, we identified three epitopes
that were commonly recognized by both mammalian (murine) and
avian (chicken, duck and goose) antibodies. These common WNV
NS1 epitopes correspond to WNV NS1 amino acids 21–36, 131–
146 and 231–246, respectively, and are referred to as peptides
NS1-3, 14 and 24. We confirmed that the NS1-3, 14 and 24 WNV
NS1 peptides were commonly recognized by murine and avian
antisera in an ELISA format. Further, the high OD at 492 nm
that was achieved in the ELISA screening against the three
common epitopes with each antiserum strongly suggests that these
linear peptide epitopes are immunodominant.
Then we compared the WNV NS1 protein sequences with
other viruses of JEV serocomplex and observed some amino acid
residues differences between different strains of which some strains
reacted with the antisera and others did not. This different
reactivity between different polypeptides were associated with the
low number of differentiating amino acids of the corresponding
epitopes in NS1 protein as shown in Figure 2. The amino acids
positions 35 (NS1-3), 237 and 240 (NS1-24) that may be crucial for
reactivity of the two WNV-specific epitopes, because the
antibodies generated following immunization with the WNV
NS1 protein that recognized the NS1-3 and 24 epitopes did not
cross react with the corresponding peptide sequences of other JEV
serocomplex viruses (Figure 2A and C). More research is needed
for further confirmation of these findings. Collectively, these
results demonstrate that the two WNV-specific common immu-
nodominant epitopes identified for the WNV NS1 protein can be
used in tandem for the rationale design of serological tests to aid
the differential diagnosis of WNV and other viruses of JEV
serocomplex infection. Additionally, although NS1 protein is
absent from the virion, it is expressed on the surface of infected
cells and can elicit non-neutralizing antibodies during infection
which are effective in protecting infected animals from lethal
flavivirus challenge [29,37]. Therefore, the mapping of antibody
epitopes specific to WNV and common to viruses of the JEV
serocomplex described in this work may be useful for the future
development of avian common subunit vaccines.
Avian species, including crows, blue jays and ravens, are the main
reservoir hosts in regions with endemic WNV. As such, these species
typically are the initial source of WNV during epizootics occurring
outside endemic areas [9,13,14,20,23–25]. Because of their close
contact with migratory birds and waterfowl, ducks and geese may
play an important role in the epidemiology of WNV. Recent works
evaluating the connection between chickens and geese in WNV and
infection with other flaviviruses suggested that chickens couldserve as
an appropriate sentinel animal for monitoring WNV epidemics
[5,6,28,30]. Additional, the three common epitopes identified did not
react with any antiserum raised against AIV, NDV, DPV and GPV,
confirmed the value of using them for serological diagnosis. As it is
difficult to obtain sera from avian species that have been naturally
infected with WNV or viruses of the JEV serocomplex in China,
future works will be needed to confirm that the peptide epitopes
identified using polyclonal sera generated against recombinant WNV
Figure 1. Identification of NS1-derived linear peptide epitopes recognized by murine and avian antibodies generated following
immunization with WNV NS1 protein. Murine, chicken, duck and goose sera were collected following immunization with recombinant WNV NS1
protein and were evaluated for reactivity against a series of peptides derived from the WNV NS1 protein by ELISA. Each bar indicates antisera
reactivity as determined by the mean absorbance at 492 nm and error bars indicate standard deviation.
doi:10.1371/journal.pone.0031434.g001
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PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e31434NS1 protein also serve as antibody epitopes following bona fide
infection with WNV.
In summary, our results identified twelve, nine and six peptide
epitopes recognized by chicken, duck and goose antibody
responses, respectively. Three epitopes (NS1-3, 14 and 24) were
recognized by antibodies elicited by immunization in all three
avian species tested. We also found that NS1-3 and 24 were
WNV-specific epitopes, whereas the NS1-14 epitope was con-
served among the JEV serocomplex viruses based on the reactivity
of avian WNV NS1 antisera against polypeptides derived from the
NS1 sequences of viruses of the JEV serocomplex. The data
described in this work will guide the development and clinical
Figure 2. Assessment of the specificity of common avian immunodominant epitopes by ELISA using polypeptides derived from
homologous regions of viruses from JEV serocomplex viruses. Chicken, duck and goose antisera immunized with WNV NS1 protein were
tested for reactivity against three corresponding polypeptides from other JEV serocomplex viruses by ELISA to identify serotype- and group-specific B
cell epitopes. For each polypeptide, the left panel displays the results of ELISA evaluating antibody binding to the JEV serocomplex peptides. Each bar
indicates antisera reactivity as determined by the mean absorbance. The right panel depicts the sequence alignments used to identify corresponding
polypeptides from representative strains of associated flavivirus isolates. The sequences from DENV1-4 and YFV are shown for comparison.
doi:10.1371/journal.pone.0031434.g002
Common Epitopes Mapped in the WNV NS1 Protein
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viruses of JEV serocomplex and also will contribute to avian
subunit vaccines development.
Materials and Methods
Ethics statement
All animal studies were approved by the Review Board of
Harbin Veterinary Research Institute, Chinese Academy of
Agricultural Sciences. The Animal Ethics Committee approval
number was Heilongjiang-SYXK 2006-032.
Avian species and proteins
WNV-negative avian species including chickens, ducks and
geese were supplied by the Centre of Experimental Animals,
Harbin Veterinary Research Institute, Chinese Academy of
Agricultural Sciences (CAAS). Purified WNV NS1 protein and
35 partially overlapping, MBP-fused polypeptides covering the
entire WNV NS1 protein (NS1-1 to NS1-35) (Data S1) were
generated in our laboratory as previously described [57].
Production and characterization of avian antisera
Chickens, ducks and geese (4 weeks old) were immunized
subcutaneously and intramuscularly with purified recombinant NS1
protein in Freund’s complete adjuvant (Sigma, St. Louis, MO, USA).
The poultry received two boosters with purified NS1 protein in
Freund’s incomplete adjuvant at 2-week intervals. Animals were bled
prior to each immunization, and one and two weeks after the final
booster to determine the titer of NS1-reactive antibodies by IFA using
WNV antigen slides. Serum collected two weeks after the final
booster was used for the epitope mapping experiments described
below. The IFA used to determine NS1-reactive antibody titers has
been described previously [57–59]. Briefly, the primary antibodies
were these sera from immunized and unimmunized chickens, ducks
and geese. The IFA titers were determined with serial two-fold
dilutions from 1:2 to 1:1024, and FITC-conjugated goat anti-chicken,
rabbit anti-duck or rabbit anti-goose secondary antibodies were
added at a 1:100, 1:50 and 1:25 dilution, respectively.
Comprehensive mapping of epitopes using avian
antisera by WB
A series of 35 partially overlapping peptides derived from the
amino acid sequence of the WNV NS1 protein were expressed as
MBP-fused polypeptides. Antibody reactivity against the MBP-
fused polypeptides were screened by WB using chicken, duck and
goose antisera. WB was performed essentially as described
previously [57]. The primary antibodies from immunized animals
or unimmunized animals were added at a 1:100 dilution, and
HRP-conjugated goat anti-chicken, rabbit anti-duck (LICOR
Biosciences) or rabbit anti-goose secondary antibodies were added
at a 1:1,000, 1:500 and 1:200 dilution, respectively.
Synthesis of candidate epitopes for confirmatory
screening of avian antisera by ELISA
The polypeptides which reacted with avian antisera by WB
were synthesized for screening in an ELISA using the avian
antisera (Table 3, Shanghai Bootech BioScience&Technology,
China). The ELISA was performed as described previously, using
synthesized polypeptides as coating antigen (100 ng/well) [57].
The irrelevant polypeptide (V5-Tag: GKPIPNPLLGLDST) and
serum from unimmunized animals served as negative controls. All
the sera were added at a 1:100 dilution. HRP-conjugated goat
anti-chicken, rabbit anti-duck (LICOR Biosciences) or rabbit anti-
goose secondary antibodies were added at a 1:2,000, 1:1,000 and
1:500 dilution, respectively. The cut-off value for the ELISA was
determined as the mean OD492 nm values of negative control
plus three standard deviations.
Analysis of antibody cross-reactivity against the common
immunodominant epitopes using polypeptides from the
NS1 protein of other JEV serocomplex viruses
Amino acid alignments were performed between the NS1
protein of WNV and other flaviviruses, including the JEV
serocomplex members Kunjin virus, JEV, SLEV and MVEV,
and the antigenically related flaviviruses DENV1–4 and YFV
Figure 3. Reactivity of AIV, NDV, DPV and GPV antisera against
the common peptide epitopes recognized by avian antisera
raised against the WNV NS1 protein. The presence of antibodies
reactive against the three common WNV NS1 epitopes in the indicated
sera were evaluated by ELISA. Each bar indicates antisera reactivity as
determined by the mean absorbance at 492 nm and error bars indicate
standard deviation.
doi:10.1371/journal.pone.0031434.g003
Table 3. Synthesized polypeptides used to identify linear
peptide epitopes recognized by avian antisera.
Peptide Designation Peptide Sequence
Peptide-NS1-1 DTGCAIDISRQELRCG
Peptide-NS1-3 IHNDVEAWMDRYKYYP
Peptide-NS1-4 RYKYYPETPQGLAKII
Peptide-NS1-6 KEGVCGLRSVSRLEHQ
Peptide-NS1-7 SRLEHQMWEAVKDELN
Peptide-NS1-8 VKDELNTLLKENGVDL
Peptide-NS1-9 ENGVDLSVVVEKQEGM
Peptide-NS1-11 PKRLTATTEKLEIGWK
Peptide-NS1-13 SILFAPELANNTFVVD
Peptide-NS1-14 NTFVVDGPETKECPTQ
Peptide-NS1-15 KECPTQNRAWNSLEVE
Peptide-NS1-18 VRESNTTECDSKIIGT
Peptide-NS1-20 NLAIHSDLSYWIESRL
Peptide-NS1-23 KSCTWPETHTLWGDGI
Peptide-NS1-24 LWGDGILESDLIIPVT
Peptide-NS1-26 RSNHNRRPGYKTQNQG
Peptide-NS1-27 KTQNQGPWDEGRVEID
Peptide-NS1-31 TTESGKLITDWCCRSC
V5-Tag GKPIPNPLLGLDST
doi:10.1371/journal.pone.0031434.t003
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31434(Lasergene, DNASTAR Inc., Madison, WI). Based on these amino
acid alignments, we identified polypeptide sequences in the JEV
serocomplex viruses and related flavivirus that corresponded to the
three common immunodominant epitopes identified within the
NS1 protein of WNV. Polypeptides of these homologous NS1
regions from the related viruses were synthesized (Table 4,
Shanghai Bootech BioScience&Technology, China). The synthe-
sized polypeptides were evaluated for reactivity with avian antisera
by ELISA as described above. An irrelevant polypeptide (V5-Tag)
and sera from unimmunized avian species served as negative
controls. The cut-off value for the ELISA was determined as the
mean OD492 nm values of negative control plus three standard
deviations.
The polypeptide sequences chosen were the predominant
amino acid residues at each position according to the alignment
results using all the available strains of certain virus in the NCBI
Entrez protein database (http://www.ncbi.nlm.nih.gov/protein/).
Evaluation of specificity of the three common peptide
epitopes
Six AIV, ten NDV, three DPV and three GPV antisera were
tested for reactivity against the common epitopes by ELISA. The
ELISA was performed as described above, using synthesized
polypeptides (Peptide-NS1-3, 14 and 24) as coating antigens. An
irrelevant polypeptide (V5-Tag) and sera from unimmunized avian
species served as negative controls, the murine WNV NS1 protein
positive serum served as positive control [57]. The cut-off value for
the ELISA was determined as the mean OD492 nm values of
negative control plus three standard deviations.
Supporting Information
Data S1 The complementary oligonucleotide pairs
encoding 35 overlapping, 16-mer peptides that encom-
passed the entire NS1 amino acid sequence from the
WNV NY99 strain.
(DOC)
Acknowledgments
The authors thank Dr. Peter Wilker for editing the manuscript.
Author Contributions
Conceived and designed the experiments: DLW. Performed the experi-
ments: ECS JZ. Analyzed the data: TY QYX YLQ NHL. Wrote the
paper: ECS JZ. Supplied the equine serum against WNV: RAL Supplied
the results of IFA: YHY Supplied the WNV NS1 gene: ZGB Revised the
manuscript: DLW LFW.
References
1. Garmendia AE, Van Kruiningen HJ, French RA (2001) The West Nile virus: its
recent emergence in North America. Microbes Infect 3: 223–229.
2. Weissenbock H, Kolodziejek J, Url A, Lussy H, Rebel-Bauder B, et al. (2002)
Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese
encephalitis virus group, central Europe. Emerg Infect Dis 8: 652–656.
3. Centers for Disease Control and Prevention (2011) West Nile Virus Human
Infections in the United States.
4. Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, et al. (2003)
Experimental Infection of North American Birds with the New York 1999 Strain
of West Nile Virus. Emerg Infect Dis 9: 311–322.
5. Langevin SA, Bunning M, Davis B, Komar N (2001) Experimental infection of
chickens as candidate sentinels for West Nile virus. Emerg Infect Dis 7: 726–729.
6. Swayne DE, Beck JR, Smith CS, Shieh WJ, Zaki SR (2001) Fatal encephalitis
and myocarditis in young domestic geese (Anser anser domesticus) caused by
West Nile virus. Emerg Infect Dis 7: 751–753.
7. Turell MJ, O’Guinn M, Oliver J (2000) Potential for New York mosquitoes to
transmit West Nile virus. Am J Trop Med Hyg 62: 413–414.
8. Sardelis MR, Turell MJ, Dohm DJ, O’Guinn ML (2001) Vector competence of
selected North American Culex and Coquillettidia mosquitoes for West Nile
virus. Emerg Infect Dis 7: 1018–1022.
9. Eidson M, Komar N, Sorhage F, Nelson R, Talbot T, et al. (2001) Crow deaths
as a sentinel surveillance system for West Nile virus in the northeastern United
States 1999. Emerg Infect Dis 7: 615–620.
10. Eidson M, Kramer L, Stone W, Hagiwara Y, Schmit K (2001) Dead bird
surveillance as an early warning system for West Nile virus. Emerg Infect Dis 7:
631–635.
11. Komar N, Panella NA, Burns JE, Dusza SW, Mascarenhas TM, et al. (2001)
Serologic evidence for West Nile virus infection in birds in the New York City
vicinity during an outbreak in 1999. Emerg Infect Dis 7: 621–625.
12. Komar N, Burns J, Dean C, Panella NA, Dusza S, et al. (2001) Serologic
evidence for West Nile virus infection in birds in Staten Island, New York, after
an outbreak in 2000. Vector Borne Zoonotic Dis 1: 191–196.
13. Bernard KA, Maffei JG, Jones SA, Kauffman EB, Ebel G, et al. (2001) West Nile
virus infection in birds and mosquitoes, New York State, 2000. Emerg Infect Dis
7: 679–685.
14. Work TH, Hurlbut HS, Taylor RM (1955) Indigenous wild birds of the Nile
delta as potential West Nile virus circulating reservoirs. Am J Trop Med Hyg 4:
872–888.
15. Komar N, Lanciotti R, Bowen R, Langevin S, Bunning M (2002) Detection of
West Nile virus in oral and cloacal swabs collected from bird carcasses. Emerg
Infect Dis 8: 741–742.
16. Semenov BF, Chunikhin SP, Karmysheva V, Iakovleva NI (1973) Study of
chronic forms of arbovirus infections in birds. I. Experiments with West Nile,
Sindbis, Bhanja and Sicilian mosquito fever viruses [Russian]. Vestn Akad Med
Nauk SSSR 28: 79–83.
17. Kuno G (2001) Persistence of arboviruses and antiviral antibodies in vertebrate
hosts: its occurrence and impacts. Rev Med Virol 11: 165–190.
18. Lvov DK, Timopheeva AA, Smirnov VA, Gromashevsky VL, Sidorova GA,
et al. (1975) Ecology of tick-borne viruses in colonies of birds in the USSR. Med
Biol 53: 325–330.
19. Steele KE, Linn MJ, Schoepp RJ, Komar N, Geisbert TW, et al. (2000)
Pathology of fatal West Nile virus infections in native and exotic birds
during the 1999 outbreak in New York City, New York. Vet Pathol 37:
208–224.
20. Panella NA, Kerst AJ, Lanciotti RS, Bryant P, Wolf B, et al. (2001) Comparative
West Nile virus detection in organs of naturally infected American Crows
(Corvus brachyrhynchos). Emerg Infect Dis 7: 754–755.
21. Kramer LD, Bernard KA (2001) West Nile virus infection in birds and
mammals. Ann N Y Acad Sci 951: 84–93.
22. Outbreak of West Nile-like viral encephalitis – New York, 1999. MMWR Morb
Mortal Wkly Rep 48: 845–849.
23. Eidson M, Komar N, Sorhage F, Nelson R, Talbot T, et al. (2001) Crow deaths
as a sentinel surveillance system for West Nile virus in the northeastern United
States 1999. Emerg Infect Dis 7: 615–620.
Table 4. Synthesized polypeptides used to assess the cross-
reactivity of antibodies that bind common avian
immunodominant epitopes in the WNV NS1 protein with
corresponding peptides derived from homologous regions of
other JEV serocomplex viruses.
Peptide Designation Peptide Sequence
Peptide-3-Kunjin virus-NS1 IHNDVEAWIDRYKYYP
Peptide-3-JEV-NS1 VHNDVEAWVDRYKYLP
Peptide-3-MVEV-NS1 IHNDVEAWIDRYKYLP
Peptide-3-SLEV-NS1 VSYDVEKWKSDYKYFP
Peptide-14-Kunjin virus-NS1 NTFVIDGPETKECPTQ
Peptide-14-JEV-NS1 STFVVDGPETKECPDE
Peptide-14-MVEV-NS1 STFVVDGPETAECPNS
Peptide-14-SLEV-NS1 NTFVVDGPETKECPTA
Peptide-24-Kunjin virus-NS1 LWGDGVLESDLIIPIT
Peptide-24-JEV-NS1 LWGDGVEESELIIPHT
Peptide-24-MVEV-NS1 LWGDAVEETELIIPVT
Peptide-24-SLEV-NS1 LWGDGVVESEMIIPVT
doi:10.1371/journal.pone.0031434.t004
Common Epitopes Mapped in the WNV NS1 Protein
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e3143424. Eidson M, Kramer L, Stone W, Hagiwara Y, Schmit K (2001) Dead bird
surveillance as an early warning system for West Nile virus. Emerg Infect Dis 7:
631–635.
25. Julian KG, Eidson M, Kipp AM, Weiss E, Petersen LR, et al. (2002) Early
season crow mortality as a sentinel for West Nile virus disease in humans,
northeastern United States. Vector Borne Zoonotic Dis 2: 145–155.
26. Office International des Epizooties (2000) West Nile fever in the United States of
America: in horses. Dis Information 13: 150–151.
27. Swayne DE, Beck JR, Zaki S (2000) Pathogenicity of West Nile virus for turkeys.
Avian Dis 44: 932–937.
28. Senne DA, Pedersen JC, Hutto DL, Taylor WD, Schmitt BJ, et al. (2000)
Pathogenicity of West Nile virus for chickens. Avian Dis 44: 642–649.
29. Langevin SA, Bowen RA, Ramey WN, Sanders TA, Maharaj PD, et al. (2011)
Envelope and pre-membrane structural amino acid mutations mediate
diminished avian growth and virulence of a Mexican West Nile virus isolate.
J Gen Virol. doi:10.1099/vir.0.035535–0.
30. Office International des Epizooties: West Nile fever in Israel in geese (1999)
Disease Information 12: 166.
31. Taylor RM, Work TH, Hurlbut HS, Rizk F (1956) A study of ecology of the
West Nile virus in Egypt. Am J Trop Med Hyg 5: 579–620.
32. Lindenbach BD, Rice CM (1997) Trans-complementation of yellow fever virus
NS1 reveals a role in early RNA replication. J Virol 71: 9608–9617.
33. Chung KM, Liszewski MK, Nybakken G, Davis AE, Townsend RR, et al.
(2006) West Nile virus nonstructural protein NS1 inhibits complement activation
by binding the regulatory protein factor H. PNAS 103: 19111–19116.
34. Chung KM, Nybakken GE, Thompson BS, Engle MJ, Marri A, et al. (2006)
Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal
infection through Fc gamma receptor-dependent and –independent mecha-
nisms. J Virol 80: 1340–1351.
35. Lin YL, Chen LK, Liao CL, Yeh CT, Ma SH, et al. (1998) DNA immunization
with Japanese encephalitis virus nonstructural protein NS1 elicits protective
immunity in mice. J Virol 72: 191–200.
36. Xu G, Xu X, Li Z, He Q, Wu B, et al. (2004) Construction of recombinant
pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2)
virus and its safety and immunogenicity. Vaccine 22: 1846–1853.
37. Chung KM, Nybakken G, Thompson BS, Engle MJ, Marri A, et al. (2006)
Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal
Infection through Fc-c Receptor-Dependent and-Independent Mechanisms.
J Virol 80: 1340–1351.
38. Lin CW, Liu KT, Huang HD, Chen WJ (2008) Protective immunity of E. coli-
synthesized NS1 protein of Japanese encephalitis virus. Biotechnol Lett 30:
205–214.
39. Amorima JH, Porchiaa BF, Balan A, Cavalcantea RC, da Costac SM, et al.
(2010) Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli
preserves structural and immunological properties of the native protein. J Virol
Methods 167: 186–192.
40. Henchal EA, Henchal LS, Schlesinger JJ (1988) Synergistic interactions of anti-
NS1 monoclonal antibodies protect passively immunized mice from lethal
challenge with dengue 2 virus. J Gen Virol 69: 2101–2107.
41. Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, et al. (2005)
Development of a humanized monoclonal antibody with therapeutic potential
against West Nile virus. Nat Med 11: 522–530.
42. Schlesinger JJ, Brandriss MW, Walsh EE (1985) Protection against 17D yellow
fever encephalitis in mice by passive transfer of monoclonal antibodies to the
nonstructural glycoprotein gp48 and by active immunization with gp48.
J Immunol 135: 2805–2809.
43. Schlesinger JJ, Foltzer M, Chapman S (1993) The Fc portion of antibody to
yellow fever virus NS1 is a determinant of protection against YF encephalitis in
mice. Virology 192: 132–141.
44. Lee TH, Song BH, Yun SI, Woo HR, Lee YM, et al. (2011) A Cross-Protective
Monoclonal Antibody Recognizes a Novel 1 Epitope within the Flavivirus NS1
protein. J Gen Virol;doi:10.1099/vir.0.036640-0.
45. Peiris JS, Gordon S, Unkeless JC, Porterfield JS (1981) Monoclonal anti-Fc
receptor IgG blocks antibody enhancement of viral replication in macrophages.
Nature 289: 189–191.
46. Mehlhop E, Ansarah-Sobrinho C, Johnson S, Engle M, Fremont DH, et al.
(2007) Complement protein C1q inhibits antibody-dependent enhancement of
flavivirus infection in an IgG subclass-specific manner. Cell Host Microbe 2:
417–426.
47. Cardosa MJ, Gordon S, Hirsch S, Springer TA, Porterfield JS (1986) Interaction
of West Nile virus with primary murine macrophages: role of cell activation and
receptors for antibody and complement. J Virol 57: 952–959.
48. Pierson TC, Xu Q, Nelson S, Oliphant T, Nybakken GE, et al. (2007) The
stoichiometry of antibody-mediated neutralization and enhancement of West
Nile virus infection. Cell Host Microbe 1: 135–145.
49. Malkinson M, Banet C, Khinich Y, Samina I, Pokamunski S, et al. (2001) Use of
live and inactivated vaccines in the control of West Nile fever in domestic geese.
Ann N Y Acad Sci 951: 255–261.
50. Shi PY, Wong SJ (2003) Serologic diagnosis of West Nile virus infection. Expert
Rev Mol Diagn 3: 733–741.
51. Koraka P, Zeller H, Niedrig M, Osterhaus AD, Groen J (2002) Reactivity of
serum samples from patients with a flavivirus infection measured by
immunofluorescence assay and ELISA. Microbes Infect 4: 1209–1215.
52. Williams DT, Daniels PW, Lunt RA, Wang LF, Newberry KM, et al. (2001)
Experimental infections of pigs with Japanese encephalitis virus and closely
related Australian flaviviruses. Am J Trop Med Hyg 65: 379–387.
53. Yoko Kitai, Mizue Shoda, Takashi Kondo, Eiji Konishi (2007) Epitope-Blocking
Enzyme-Linked Immunosorbent Assay To Differentiate West Nile Virus from
Japanese Encephalitis Virus Infections in Equine Sera. Clin Vaccine Immunol
14: 1024–1031.
54. Yoko Kitai, Kondo T, Konishi E (2010) Complement-dependent cytotoxicity
assay for differentiating West Nile virus from Japanese encephalitis virus
infections in horse sera. Clin Vaccine Immunol 17: 875–878.
55. Kitai Y, Kondo T, Konishia E (2011) Non-structural protein 1 (NS1) antibody-
based assays to differentiate West Nile (WN) virus from Japanese encephalitis
virus infections in horses: Effects of WN virus NS1 antibodies induced by
inactivated WN vaccine. J Virol Methods 171: 123–128.
56. Kitai Y, Shirafuji H, Kanehira K, Kamio T, Kondo T, et al. (2011) Specific
Antibody Responses to West Nile Virus Infections in Horses Preimmunized with
Inactivated Japanese Encephalitis Vaccine: Evaluation of Blocking Enzyme-
Linked Immunosorbent Assay and Complement-Dependent Cytotoxicity Assay.
Vector-borne and Zoonotic Dis 11: 1093–1098.
57. Sun EC, Zhao J, Liu NH, Yang T, Ma JN, et al. (2011) Comprehensive mapping
of WNV- and JEV serocomplex- specific linear B-cell epitopes from West Nile
virus nonstructural protein 1. J Gen Virol. doi:10.1099/vir.0.034900-0.
58. Sun EC, Ma JN, Liu NH, Yang T, Zhao J, et al. (2011) Identification of two
linear B-cell epitopes from West Nile virus NS1 by screening a phage displayed
random peptide library. BMC Microbiol 11: 160.
59. Sun EC, Zhao J, Yang T, Liu NH, Geng HW, et al. (2011) Identification of a
conserved JEV serocomplex B-cell epitope by screening a phage-display peptide
library with a mAb generated against West Nile virus capsid protein. Virol J 8:
100.
Common Epitopes Mapped in the WNV NS1 Protein
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31434